• Citer

186P Pooled efficacy and safety data of alectinib (A) vs. crizotinib (C) from the randomized phase III ALEX and J-ALEX trials

par Tagliamento, Marco;Bruzzone, Marco;Ceppi, Marcello;Genova, Carlo;Dall'Olio, F.G.;Aldea, Mihaela;Spagnolo, Francesco;Blondeaux, Eva;Poggio, Francesca;Brandão, Mariana ;Remon Masip, J.;Del Mastro, Lucia;Hendriks, Lizza;Barlesi, Fabrice;Planchard, David;Lambertini, Matteo ;Besse, Benjamin
Référence Annals of oncology, 34, page (S255-S256)
Publication Publié, 2023-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	186P Pooled efficacy and safety data of alectinib (A) vs. crizotinib (C) from the randomized phase III ALEX and J-ALEX trials
Auteur:	Tagliamento, Marco; Bruzzone, Marco; Ceppi, Marcello; Genova, Carlo; Dall'Olio, F.G.; Aldea, Mihaela; Spagnolo, Francesco; Blondeaux, Eva; Poggio, Francesca; Brandão, Mariana; Remon Masip, J.; Del Mastro, Lucia; Hendriks, Lizza; Barlesi, Fabrice; Planchard, David; Lambertini, Matteo; Besse, Benjamin
Informations sur la publication:	Annals of oncology, 34, page (S255-S256)
Statut de publication:	Publié, 2023-10
Sujet CREF:	Cancérologie
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1016/j.annonc.2023.09.2910
	info:pii/S092375342303747X